• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·688338.SS
Share

Beijing Succeeder Technology Inc. Stocks

CN¥ 29.41Last Updated 09.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Moderate

Recommendation

Hold

Market Cap

CN¥ 492.38M

CN¥ 29.41
Key Takeaways

Risk factor

Very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Beijing Succeeder Technology Inc. specializes in the development, production, and distribution of in-vitro diagnostic (IVD) products, serving markets both domestically within China and internationally. The company provides a comprehensive portfolio of diagnostic equipment, including coagulation analyzers and their associated reagents, blood rheology analyzers, erythrocyte sedimentation rate (ESR) analyzers, and platelet aggregation analyzers. Established in 2003, its main operational base is located in Beijing, China.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.10.2026 00:49

What do analysts think about Trump's announced Russia-Ukraine energy ceasefire?

11.10.2026 21:01

IPO roundup: Firmus collapse sends AI funding warning; DeepSeek seeking $12 bln

11.10.2026 09:19

Twelve killed in attack on Riyadh airport

10.10.2026 16:01

Small caps last week: Webull risks, Levi’s outlook, Vaxcyte trial success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026